Fulminant and Non-fulminant Clinical COVID-19 Myocarditis in the New York City Area in 2020
By: Christopher Wong, Amtul Mansoor and Thomas McGinn
References
- Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: A review. JAMA Cardiol. 2020; 5(7): 831–840. DOI: 10.1001/jamacardio.2020.1286
- Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7): 819–824. DOI: 10.1001/jamacardio.2020.1096
- Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020; 45(3): 230–232. DOI: 10.1007/s00059-020-04909-z
- Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Hear Rhythm. 2020; 17(9): 1463–1471. DOI: 10.1016/j.hrthm.2020.05.001
- Zeng J-H, Liu Y-X, Yuan J, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. April 2020; 1–5. DOI: 10.1007/s15010-020-01424-5
- Buttà C, Zappia L, Laterra G, Roberto M. Diagnostic and prognostic role of electrocardiogram in acute myocarditis: A comprehensive review. Ann noninvasive Electrocardiol Off J Int Soc Holter Noninvasive Electrocardiology, Inc. 2020; 25(3). DOI: 10.1111/anec.12726
- Kociol RD, Cooper LT, Fang JC, et al. Recognition and initial management of fulminant myocarditis: A scientific statement from the American Heart Association. Circulation. 2020; 141(6): e69–e92. DOI: 10.1161/CIR.0000000000000745
- Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020; 22(5): 911–915. DOI: 10.1002/ejhf.1828
- Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. July 2020. DOI: 10.1001/jamacardio.2020.3557
- Sawalha K, Abozenah M, Kadado AJ, et al. Systematic review of COVID-19 related myocarditis: Insights on management and outcome. Cardiovasc Revasc Med. August 2020; S1553-8389(20): 30497–8. DOI: 10.1016/j.carrev.2020.08.028
- Harris JE, Shah PJ, Korimilli V, Win H. Frequency of troponin elevations in patients with influenza infection during the 2017-2018 influenza season. Int J Cardiol Hear Vasc. 2019; 22: 145–147. DOI: 10.1016/j.ijcha.2018.12.013
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054–1062. DOI: 10.1016/S0140-6736(20)30566-3
- Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34(33): 2636–2648. DOI: 10.1093/eurheartj/eht210
- Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020; 20(6): 363–374. DOI: 10.1038/s41577-020-0311-8
- Kariyanna PT, Sutarjono B, Grewal E, et al. A systematic review of COVID-19 and myocarditis. Am J Med Case Reports. 2020; 8(9): 299–305. DOI: 10.12691/ajmcr-8-9-11
DOI: https://doi.org/10.5334/aogh.3583 | Journal eISSN: 2214-9996
Language: English
Published on: Mar 8, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2022 Christopher Wong, Amtul Mansoor, Thomas McGinn, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.